BackABVC BioPharma Overview

ABVC BioPharma Receivables

Latest receivables for ABVC: $29K.

Get informed when a big investor buys or sells

+ Follow
Receivables
$29462.00

Peer trimmed avg / median

Loading

ABVC BioPharma Receivables History

Loading

ABVC BioPharma vs. peers: Receivables Comparison

Loading

ABVC BioPharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ABVC BioPharma (ABVC) FAQ

ABVC BioPharma (ABVC) currently reports a receivables of $29K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore ABVC BioPharma's receivables history and peer comparisons.

ABVC BioPharma's receivables changed from $0 to $29K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ABVC BioPharma reported $29K in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $29K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ABVC BioPharma, and consider following ABVC for alerts when major investors trade the stock.

ABVC BioPharma is classified in the Industrials sector. On receivables, it currently shows $29K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing ABVC with unrelated industries.